‘Shrunken pore syndrome’ flags mortality risk in T2DM: Aussie study
A low ratio of cystatin C–based eGFR to creatinine-based eGFR in people with type 2 diabetes is linked to mortality regardless of conventional markers of…
Tag: Endocrinology – Diabetes
Hundreds of doctors sent warnings for prescribing semaglutide on PBS to patients without diabetes
Health officials have started a mass letter mail-out to doctors they suspect are using the PBS to prescribe subsidised semaglutide to patients without diabetes. Without…
Certain diabetes drugs cut risk of COPD exacerbations: study
Patients with type 2 diabetes and COPD are up to 20% less likely to experience respiratory exacerbations when treated with SGLT-2 inhibitors or GLP-1 receptor…
GLP-1 RAs linked to eye complications in JAMA case series
A case series has rekindled concerns about potential eye-related complications associated with semaglutide and tirzepatide. Published in JAMA Ophthalmology, it documents instances of serious ophthalmic…
‘Medicine is witchcraft’: Parents who believed God would cure daughter’s diabetes found guilty of manslaughter
All 14 members of a fringe religious group have been found guilty of the manslaughter of an eight-year-old who died after her insulin was withheld.…
Smartphone-supported CGM a diabetes game changer
Pat is a 56-year-old accountant and avid horse rider who has type 1 diabetes. She self-presents to a local diabetes education clinic after years of…
The real Professor Jonathan Shaw talks to AusDoc about his AI deepfake and the wider threat to medicine
Leading endocrinologist Professor Jonathan Shaw was on holiday on K’gari (Fraser Island) off the coast of Queensland, with the patchy reception that entails, when he…
Leading endocrinologist victim of deepfake AI scam showing him describe doctors as ‘idiots’
A leading endocrinologist has been the victim of a bizarre deepfake scam, with a news item fabricated by AI showing him describing doctors who prescribe…
SGLT-2 inhibitors stave off type 2 diabetes in HF, studies show
New analyses of trial data suggest SGLT-2 inhibitors reduce incident diabetes in patients with cardiovascular or kidney disease, a team of international researchers says. Dapagliflozin…
GLP-1 receptor agonists ‘reduce kidney failure and deaths’: meta-analysis
GLP-1 receptor agonists offer significant renal protection as well as cardiovascular benefits, a meta-analysis shows. Australian-led research has found that patients taking the drugs have…
